Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11060078 Engineered CRISPR-Cas9 nucleases

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
January 6, 2020
Date of Patent
July 13, 2021
Patent Application Number
16734935
Patent Citations
‌
US Patent 10138476 Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing
0
‌
US Patent 10378027 RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
0
‌
US Patent 10415059 Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
‌
US Patent 10526589 Multiplex guide RNAs
‌
US Patent 10526591 Engineered CRISPR-Cas9 nucleases
‌
US Patent 10760064 RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
0
‌
US Patent 10544433 Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing
‌
US Patent 10844403 Increasing specificity for RNA-guided genome editing
‌
US Patent 10011850 Using RNA-guided FokI Nucleases (RFNs) to increase specificity for RNA-Guided Genome Editing
‌
US Patent 10119133 Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
Patent Inventor Names
Vikram Pattanayak
0
Benjamin Kleinstiver
0
J. Keith Joung
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11060078
Patent Primary Examiner
‌
Karen Cochrane Carlson

Find more entities like US Patent 11060078 Engineered CRISPR-Cas9 nucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo